Turning Point Benefit Group’s Hologic HOLX Stock Holding History

Turning Point Benefit Group’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3	Closed	-$223	–	401
2025 Q4	$223	Hold	3	–	–	﹤0.01%	749
2025 Q3	$201	Buy	+3	New	+$199	﹤0.01%	653

Other funds holding HOLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Turning Point Benefit Group's HOLX Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Hologic (HOLX) in Q1 2026, closing a stake of 3 shares — an estimated $223 sold.

Turning Point Benefit Group first reported a position in HOLX in Q3 2025 and held it in 2 quarters. The position peaked at $223 in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

Turning Point Benefit Group reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 3 Hologic shares in Q1 2026, an estimated $223.
Turning Point Benefit Group first reported a position in Hologic in Q3 2025 and held it in 2 quarters.
Turning Point Benefit Group's Hologic position peaked at $223 in Q4 2025.
704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.